Eleven TherapeuticsEleven Therapeutics
Eleven Therapeutics

Eleven Therapeutics

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Website
2017Active28
Advertise here

About

Eleven Therapeutics is a biotechnology company focused on developing novel RNA-based therapeutics for rare genetic diseases. Founded by world-class scientists, the company leverages its proprietary platform to design and deliver targeted therapies. Eleven Therapeutics aims to address unmet medical needs in patients with debilitating genetic conditions.

Technology stack

detected 2026-06-11
Est. monthly stack spend~$360/mo
EmailGoogle Workspace
Hosting
self_managed
Stack
BootstrapWordPress
Analytics
Google Analytics 4
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Eleven Therapeutics do?

Eleven Therapeutics is a biotechnology company focused on developing novel RNA-based therapeutics for rare genetic diseases. Founded by world-class scientists, the company leverages its proprietary platform to design and deliver targeted therapies. Eleven Therapeutics aims to address unmet medical needs in patients with debilitating genetic conditions.

How much funding has Eleven Therapeutics raised?

Eleven Therapeutics has raised a total of $22M in funding. The most recent round on record is Seed.

Where is Eleven Therapeutics headquartered?

Eleven Therapeutics is headquartered in London, United Kingdom.

When was Eleven Therapeutics founded?

Eleven Therapeutics was founded in 2017.

What industry does Eleven Therapeutics operate in?

Eleven Therapeutics operates in Healthcare, Life Sciences, Therapeutics, Biotech, HealthTech, Drug Discovery.

How many employees does Eleven Therapeutics have?

Eleven Therapeutics has approximately 28 people on record.